Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjili Mathur

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Biomolecular Screening|May 1, 2009
Development of a cell-based assay for measurement of c-Met phosphorylation using AlphaScreen technology and high-content imaging analysisNadya Smotrov, Anjili Mathur, Ilona Kariv, et al.
Journal of Neurochemistry|June 18, 2002
Trophic agents that prevent neuronal apoptosis activate calpain and down-regulate CaMKIVBarbara Tremper-Wells, Anjili Mathur, Carol M Beaman-Hall, et al.
Biochemical Pharmacology|May 8, 2004
Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neuronsEdward A Monaco, Carol M Beaman-Hall, Anjili Mathur, et al.
Journal of Neurochemistry|April 21, 2010
Reduced blockade by extracellular Mg(2+) is permissive to NMDA receptor activation in cerebellar granule neurons that model a migratory phenotypeAdam M Gerber, Carol M Beaman-Hall, Anjili Mathur, et al.
Plos One|June 27, 2014
FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survivalAnjili Mathur, Christopher Ware, Lenora Davis, et al.
Plos One|October 1, 2009
Splenectomy normalizes hematocrit in murine polycythemia veraJan-Rung Mo, Anjili Mathur, Minilik Angagaw, et al.
Investigational New Drugs|December 1, 2011
MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiationLi Wang, Kathy A Mason, K Kian Ang, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2014
The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: lead optimizationTony Siu, Sathyajith E Kumarasinghe, Michael D Altman, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2014
Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasmsAndrew M Haidle, Anna A Zabierek, Kaleen K Childers, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2010
The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to leadTony Siu, Ekaterina S Kozina, Joon Jung, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Biomolecular Screening|May 1, 2009
Development of a cell-based assay for measurement of c-Met phosphorylation using AlphaScreen technology and high-content imaging analysisNadya Smotrov, Anjili Mathur, Ilona Kariv, et al.
Journal of Neurochemistry|June 18, 2002
Trophic agents that prevent neuronal apoptosis activate calpain and down-regulate CaMKIVBarbara Tremper-Wells, Anjili Mathur, Carol M Beaman-Hall, et al.
Biochemical Pharmacology|May 8, 2004
Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neuronsEdward A Monaco, Carol M Beaman-Hall, Anjili Mathur, et al.
Journal of Neurochemistry|April 21, 2010
Reduced blockade by extracellular Mg(2+) is permissive to NMDA receptor activation in cerebellar granule neurons that model a migratory phenotypeAdam M Gerber, Carol M Beaman-Hall, Anjili Mathur, et al.
Plos One|June 27, 2014
FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survivalAnjili Mathur, Christopher Ware, Lenora Davis, et al.
Plos One|October 1, 2009
Splenectomy normalizes hematocrit in murine polycythemia veraJan-Rung Mo, Anjili Mathur, Minilik Angagaw, et al.
Investigational New Drugs|December 1, 2011
MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiationLi Wang, Kathy A Mason, K Kian Ang, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2014
The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: lead optimizationTony Siu, Sathyajith E Kumarasinghe, Michael D Altman, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2014
Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasmsAndrew M Haidle, Anna A Zabierek, Kaleen K Childers, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2010
The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to leadTony Siu, Ekaterina S Kozina, Joon Jung, et al.
Pageof 2